Daniel Sutcliffe is a highly accomplished professional with a diverse background spanning across pharmacy, healthcare, and management. He earned a First-Class Master's degree in Pharmacy from the University of Kent and has since held various roles in the industry. Sutcliffe is currently the Patient & Market Access Manager at COMPASS Pathways, where he oversees the coordination of clinical trials and the development of psychedelic therapeutics for mental health disorders. He has previously worked as a Senior Associate and Associate in pricing and market access consulting at PAREXEL, as well as a freelance scientific writer at RIG Healthcare Ltd. His experience also includes a role as a Pharmacy Engagement Executive at the Royal Pharmaceutical Society. Prior to his career in healthcare and management, he worked as an Assistant Quantity Surveyor at Bowmer & Kirkland Ltd.

Sutcliffe's keen attention to detail, analytical skills, and expertise in healthcare, pharmaceuticals, and management make him an asset to any organization. His interests in clinical research, market access, and patient outcomes align with his current role at COMPASS Pathways and show his dedication to improving patient health outcomes.